Medicare Coverage Analysis Of Alzheimer’s Drugs Begins With Focus On Outcomes, Patient Eligibility

 
• By Cathy Kelly
  
Decision Could Set A Precedent For Accelerated Approval Drugs

More from Medicare

More from Government Payers